REED JOHN C (EVP, Innovative Medicine, R&D) exercised options at JOHNSON & JOHNSON
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 5/4/2026ACC: 0000200406-26-000115
Officer· EVP, Innovative Medicine, R&D
Since Feb 2026
-11K
Net shares
Net seller
$2.53M
Total sold
0
Open market trades
0B · 0S
3
Total transactions
25.25K acquired · 36.26K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+25.25K
Price / share
—
Trade value
—
% of position
237.0%
5/1/2026
10.66K→35.91K
Common Stock
Direct
Shares
−11K
Price / share
$229.85
Trade value
$2.53M
% of position
30.6%
5/1/2026
35.91K→24.91K
Total
Net shares
+14.25K
Net value
-$2.53M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2026 | M · Option Exercise | +25.25K | — | — | 237.0% | 10.66K | 35.91K |
| Common Stock Direct | 5/1/2026 | F · Tax Withholding | −11K | $229.85 | $2.53M | 30.6% | 35.91K | 24.91K |
| Total | +14.25K | -$2.53M | ||||||
Derivative Transactions1
Restricted Share Units
Direct
Converts to
Common Stock
25.25K shares
Shares
−25.25K
Strike price
Held after
0.00
Exercisable
—
5/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Common Stock25.25K shares | 5/1/2026 | M · Option Exercise | −25.25K | — | 0.00 |